Article: Connetics Announces Agreement With Distributor of Soriatane to Select International Markets.

Potential to Generate Incremental $11.0 Million to $13.0 Million in Annual Product Sales

Connetics Corporation , a specialty pharmaceutical company that develops and commercializes dermatology products, today reported it has signed a multi-year consent with Roche to sell Soriatane(R) to a U.S.-based distributor that exports branded pharmaceutical products to select international markets. Connetics estimates that sales to this distributor could potentially generate an incremental $11.0 million to $13.0 million in Soriatane sales annually through 2007. Product sold to this distributor is not permitted to be resold in the U.S. Under the terms of the agreement, ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!